These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity. Bakheit AM J Neurol Neurosurg Psychiatry; 2004 May; 75(5):665-6. PubMed ID: 15090554 [No Abstract] [Full Text] [Related]
23. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529 [TBL] [Abstract][Full Text] [Related]
24. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341 [TBL] [Abstract][Full Text] [Related]
25. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke. Demetrios M; Brand C; Louie J; Khan F J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568 [TBL] [Abstract][Full Text] [Related]
26. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724 [TBL] [Abstract][Full Text] [Related]
27. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601 [TBL] [Abstract][Full Text] [Related]
28. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial. Kerzoncuf M; Viton JM; Pellas F; Cotinat M; Calmels P; Milhe de Bovis V; Delarque A; Bensoussan L Arch Phys Med Rehabil; 2020 Feb; 101(2):242-248. PubMed ID: 31469982 [TBL] [Abstract][Full Text] [Related]
29. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin. Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700 [TBL] [Abstract][Full Text] [Related]
30. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C; N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol. Chu WH; Gupta AD JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics]. Yelnik AP Ann Readapt Med Phys; 2004 Oct; 47(8):575-89. PubMed ID: 15465163 [TBL] [Abstract][Full Text] [Related]
33. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke. Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161 [TBL] [Abstract][Full Text] [Related]
35. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients. Albani G; Cimolin V; Galli M; Vimercati S; Bar D; Campanelli L; Gandolfi R; Lombardi R; Mauro A Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type A for refractory post-stroke shoulder pain. Pedreira G; Cardoso E; Melo A Arq Neuropsiquiatr; 2008 Jun; 66(2A):213-5. PubMed ID: 18545785 [TBL] [Abstract][Full Text] [Related]
37. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045 [TBL] [Abstract][Full Text] [Related]
38. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study. Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117 [TBL] [Abstract][Full Text] [Related]
39. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Gordon MF; Brashear A; Elovic E; Kassicieh D; Marciniak C; Liu J; Turkel C; Neurology; 2004 Nov; 63(10):1971-3. PubMed ID: 15557529 [TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A in post-stroke upper limb spasticity. Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M; Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]